Holen Sie sich die Stockscreener-App
3.49
6.59%
-0.15
Handel nachbörslich:
3.38
-0.11
-3.15%
Schlusskurs vom Vortag:
$3.64
Offen:
$3.47
24-Stunden-Volumen:
5.47M
Relative Volume:
1.23
Marktkapitalisierung:
$12.12M
Einnahmen:
$2.49M
Nettoeinkommen (Verlust:
$-21.46M
KGV:
-0.1787
EPS:
-19.526
Netto-Cashflow:
$-21.50M
1W Leistung:
+69.15%
1M Leistung:
+211.93%
6M Leistung:
-66.00%
1J Leistung:
-86.53%
1-Tages-Spanne:
$3.10
$3.64
1-Wochen-Bereich:
$1.83
$4.3099
52-Wochen-Spanne:
$0.9631
$34.75
Geovax Labs Inc Stock (GOVX) Company Profile
Firmenname
Geovax Labs Inc
Sektor
Branche
Telefon
678-384-7220
Adresse
1955 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
3.49 | 12.64M | 2.49M | -21.46M | -21.50M | -19.53 |
VRTX
Vertex Pharmaceuticals Inc
|
436.05 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.35 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-04-15 | Bestätigt | Alliance Global Partners | Buy |
| 2025-04-15 | Bestätigt | D. Boral Capital | Buy |
| 2024-11-11 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-16 | Eingeleitet | ROTH MKM | Buy |
| 2020-11-19 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Geovax Labs Inc Aktie (GOVX) Neueste Nachrichten
GeoVax Labs (GOVX) Narrows Focus on Key Development Programs - GuruFocus
GOVX Faces 11% Decline Following Suspension of COVID Vaccine Ini - GuruFocus
GeoVax Labs (GOVX) Shifts Focus from COVID Vaccine to Smallpox P - GuruFocus
Why Is GOVX Stock Falling Today? - Yahoo Finance
GeoVax (GOVX) resale S-1 shows 7.6M warrant shares and tight cash runway - Stock Titan
GeoVax Accelerates Focus on GEO-MVA Commercialization and Advancement of Oncology Program Gedeptin(R) - Yahoo Finance
How The GeoVax Labs (GOVX) Story Is Shifting With Vaccine Progress And Funding Risks - Yahoo Finance
GOVX Jumps As GeoVax Wins Bullish Ebola Vaccine Call - timothysykes.com
WHO Africa Chief Warns It's A 'Big Mistake' To Underestimate Ebola Outbreak As Deadly Virus Spreads Beyond Congo - Benzinga
Geovax Labs Analyst Ratings and Price Targets | NASDAQ:GOVX - Benzinga
Geovax Labs Inc (GOVX) Stock Price, Quote, News & History - Benzinga
GOVX Stock Jumps As Noble Capital Targets $10 On Ebola Vaccine Hopes - StocksToTrade
GOVX Stock Jumps As Noble Capital Reaffirms $10 Target - timothysykes.com
GOVX Stock Chart | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax Labs Q1 2026 Earnings: Significant EPS Beat Drives Stock SurgeRevenue Surprise History - Newser
GOVX Technical Analysis | Trend, Signals & Chart Patterns | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
Q1 2025 GeoVax Labs Inc Earnings Call Transcript - GuruFocus
Is GeoVax Labs (GOVX) Still a Buy After +15.92% Rally? 2026-05-20Trading Community - Newser
GeoVax Stock Higher As Company Highlights MVA Platform For Ebola Threats - Benzinga
GeoVax Highlights Need for Flexible Vaccine Platforms Amid Bundibugyo Ebola Outbreak - MEXC
GOVX Stock Became A Hot Biodefense Trade Amid Ebola, Hantavirus Concerns - Stocktwits
GeoVax Comments on Escalating Bundibugyo Ebola Outbreak and Growing Need for Flexible Biodefense Vaccine Platforms - Yahoo Finance
GeoVax Labs Announces Private Placement Offering with Pre-Funded and Common Stock Purchase Warrants – Details and Agreements Included - Minichart
GeoVax Raises $3 Million via Private Placement Financing - TipRanks
GeoVax Raises $2.7 Million Net in Private Placement of Pre-Funded and Common Warrants - TradingView
GeoVax (NASDAQ: GOVX) prices $3M warrant-based private financing - Stock Titan
Why is GeoVax Labs stock falling Tuesday? - MSN
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Why Is GeoVax Labs Stock Falling Tuesday? - Benzinga
GOVX Stock Sees Volatile Spike As Traders Eye Momentum - timothysykes.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight - TechStock²
GOVX stock soars 80%: Retail traders are piling in as Ebola, hantavirus risks resurface - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Sahm
GeoVax Labs, Inc. announced that it has received $3 million in funding - marketscreener.com
GeoVax Raises $3 Million in Private Placement for Working Capital and General Corporate Purposes - MEXC
GeoVax Labs, Inc. announced that it expects to receive $3 million in funding - marketscreener.com
GeoVax Labs (NASDAQ: GOVX) asks shareholders to permit issuance of warrants converting to shares - Stock Titan
GeoVax Highlights Need for Domestic MVA Vaccine Infrastructure Amid Global Health Emergencies - citybuzz -
GeoVax Highlights Strategic Importance of Domestic MVA-Based Preparedness Infrastructure Amid Escalating Global Infectious Disease Threats - Yahoo Finance
GOVX Stock Rockets On Heavy Volume As Traders Pile In - StocksToTrade
GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules - The Globe and Mail
GeoVax Labs (GOVX) jumps 178% as traders refocus on mpox vaccine thesis after recent Q1 update - Quiver Quantitative
$GeoVax Labs (GOVX.US)$ Never trapped - Moomoo
GOVX Stock Volatility Draws Trader Attention Amid Weak Fundamentals - timothysykes.com
All you need to know about GeoVax Labs (GOVX) rating upgrade to buy - MSN
GeoVax Jumps Pre-market as Traders Eye Biotech’s Mpox Vaccine Push - TechStock²
$GeoVax Labs (GOVX.US)$ [Sob][Sob] Made some profit but it was a hidden loss, thank you everyone - Moomoo
$GeoVax Labs (GOVX.US)$ thank you - Moomoo
$GeoVax Labs (GOVX.US)$ havent sell all yet :) - Moomoo
Roth MKM Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Finanzdaten der Geovax Labs Inc-Aktie (GOVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
2.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):